$AGIO News Article - Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia https://marketwirenews.com/news-releases/agio...67833.html
(0)
(0)
Agios Pharmaceuticals Inc. (AGIO) Stock Research Links